Investors

Statement of Cash Flows

 Half-Year Financial Report 2024

  Q2 H1
Million € 2024 2023 2024 2023
Net income 430 499 1,797 2,061
Depreciation and amortization of intangible assets and property, plant and equipment and intangible assetsa 1,047 934 2,012 1,878
Equity-accounted income –83 –118 –350 –377
Other noncash items 23 38 94 –56
Gains (–) / losses (+) from the disposal of noncurrent assets and securities –8 –74 –35 –88
Dividends received from equity-accounted investments 76 438 88 471
Changes in inventories –403 608 –720 418
Changes in accounts receivable, trade 1,028 1,398 –1,767 –896
Changes in accounts payable, trade 86 –1,178 0 –2,302
Changes in provisions –203 –433 949 288
Changes in other operating assets –283 291 –403 519
Changes in other operating liabilities and pension provisions 241 –225 –230 –754
Cash flows from operating activities   1,951   2,178   1,437   1,163
         
Payments made for property, plant and equipment and intangible assets –1,480 –1,273 –2,423 –2,140
Payments made for financial assets and securities  –804 –207 –969 –366
Payments made for acquisitions –169 –202
Payments received for divestitures 17 33 22
Payments received from the disposal of noncurrent assets and securities 288 206 552 506
Cash flows from investing activities –2,147 –1,274 –3,010 –1,978
         
Capital increases/repayments and other equity transactions –70
Additions to financial and similar liabilities 3,066 3,779 5,482 7,459
 Repayment of financial and similar liabilities –332 –1,635 –1,173 –3,436
 Dividends paid –3,088 –3,078 –3,125 –3,078
Cash flows from financing activities –354 –934 1,184 874
         
Cash-effective changes in cash and cash equivalents –551 –30 –388 59
Changes in cash and cash equivalents from foreign exchange rates and changes in the scope of consolidation –6 –58 –7 –100
Cash and cash equivalents at the beginning of the period 2,786 2,562 2,624 2,516
Cash and cash equivalents at the end of the period 2,229 2,474 2,229 2,474

a This item includes depreciation and amortization, impairments and reversals of impairments.

Last Update July 26, 2024